Company registration number 13867613 (England and Wales)
LUV NURSERIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
LUV NURSERIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
LUV NURSERIES LIMITED
BALANCE SHEET
AS AT
30 JUNE 2025
30 June 2025
- 1 -
30 June 2025
31 January 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
27,156
-
0
Investments
4
100
100
27,256
100
Current assets
Debtors
5
3,808
1,086
Cash at bank and in hand
20,370
65
24,178
1,151
Creditors: amounts falling due within one year
6
(496,336)
(206,485)
Net current liabilities
(472,158)
(205,334)
Net liabilities
(444,902)
(205,234)
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
(445,002)
(205,334)
Total equity
(444,902)
(205,234)

For the financial period ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 3 November 2025 and are signed on its behalf by:
Mr C J Twist
Director
Company registration number 13867613 (England and Wales)
LUV NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2025
- 2 -
1
Accounting policies
Company information

LUV Nurseries Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1 Stanley Lane, Aspull, Wigan, WN2 1WT.

1.1
Reporting period

The financial statements cover the reporting period from 01 February 2024 to 30 June 2025, which is a period of 18 months.

This reporting period differs from the previous period, which covered 12 months from 1 February 20 23 to 31 January 2 024, due to change in year-end date.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

LUV NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 3 -

The financial statements have been prepared on a going concern basis. The directors have assessed the company's current financial position and future prospects and have reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Classroom resources
15% on cost
Fixtures and fittings
15% on cost
1.6
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

LUV NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 4 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

LUV NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
1
Accounting policies
(Continued)
- 5 -

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2025
2024
Number
Number
Total
6
2
3
Tangible fixed assets
Classroom resources
Fixtures and fittings
Total
£
£
£
Cost
At 1 February 2024
-
0
-
0
-
0
Additions
28,706
2,027
30,733
At 30 June 2025
28,706
2,027
30,733
Depreciation and impairment
At 1 February 2024
-
0
-
0
-
0
Depreciation charged in the period
3,413
164
3,577
At 30 June 2025
3,413
164
3,577
Carrying amount
At 30 June 2025
25,293
1,863
27,156
At 31 January 2024
-
0
-
0
-
0
LUV NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2025
- 6 -
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
100
100
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
854
-
0
Amounts owed by group undertakings
234
234
Other debtors
-
0
852
Prepayments and accrued income
2,720
-
0
3,808
1,086
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
219,750
-
0
Pension control account
7,668
747
Other creditors
266,418
205,018
Accruals and deferred income
2,500
720
496,336
206,485
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
ordinary of £1 each
100
100
100
100
2025-06-30 2024-02-01 false false false 05 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr C J Twist Mrs H L Twist 13867613 2024-02-01 2025-06-30 13867613 2025-06-30 13867613 2024-01-31 13867613 core:PlantMachinery 2025-06-30 13867613 core:FurnitureFittings 2025-06-30 13867613 core:PlantMachinery 2024-01-31 13867613 core:FurnitureFittings 2024-01-31 13867613 core:CurrentFinancialInstruments 2025-06-30 13867613 core:CurrentFinancialInstruments 2024-01-31 13867613 core:ShareCapital 2025-06-30 13867613 core:ShareCapital 2024-01-31 13867613 core:RetainedEarningsAccumulatedLosses 2025-06-30 13867613 core:RetainedEarningsAccumulatedLosses 2024-01-31 13867613 core:ShareCapitalOrdinaryShareClass1 2025-06-30 13867613 core:ShareCapitalOrdinaryShareClass1 2024-01-31 13867613 bus:Director1 2024-02-01 2025-06-30 13867613 core:PlantMachinery 2024-02-01 2025-06-30 13867613 core:FurnitureFittings 2024-02-01 2025-06-30 13867613 2023-02-01 2024-01-31 13867613 core:PlantMachinery 2024-01-31 13867613 core:FurnitureFittings 2024-01-31 13867613 2024-01-31 13867613 bus:OrdinaryShareClass1 2024-02-01 2025-06-30 13867613 bus:OrdinaryShareClass1 2025-06-30 13867613 bus:OrdinaryShareClass1 2024-01-31 13867613 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-06-30 13867613 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-06-30 13867613 bus:FRS102 2024-02-01 2025-06-30 13867613 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-06-30 13867613 bus:Director2 2024-02-01 2025-06-30 13867613 bus:FullAccounts 2024-02-01 2025-06-30 xbrli:pure xbrli:shares iso4217:GBP